Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Nature Communications

Volumn 4, Issue , 2013, Pages

  Mederacke, Ingmar ^a   Hsu, Christine C ^a   Troeger, Juliane S ^a   Huebener, Peter ^a   Mu, Xueru ^a   Dapito, Dianne H ^a   Pradere, Jean Philippe ^a   Schwabe, Robert F ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASE INCIDENCE; DOMINANCE; MORTALITY; RODENT;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; INTRAHEPATIC BILE DUCT; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MOUSE; MYOFIBROBLAST; NONALCOHOLIC FATTY LIVER; NONHUMAN; PERICYTE; STELLATE CELL; STEM CELL; TRANSGENIC MOUSE;

MUS MUSCULUS;

ANIMALS; FEMALE; GENES, REPORTER; HEPATIC STELLATE CELLS; INTEGRASES; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MYOFIBROBLASTS;

EID: 84888339170     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3823     Document Type: Article

References (55)

1. Mehal, W. Z., Iredale, J. & Friedman, S. L. Scraping fibrosis: expressway to the core of fibrosis. Nat. Med. 17, 552-553 (2011).
2. Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500-503 (2003). (Pubitemid 36818250)
3. Wynn, T. A. & Ramalingam, T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028-1040 (2012).
4. Bataller, R. & Brenner, D. A. Liver fibrosis. J. Clin. Invest. 115, 209-218 (2005). (Pubitemid 40385459)
5. Dranoff, J. A. & Wells, R. G. Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 51, 1438-1444 (2010).
6. Iwaisako, K., Brenner, D. A. & Kisseleva, T. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J. Gastroenterol. Hepatol. 27, 65-68 (2012).
7. Perepelyuk, M. et al. Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G605-G614 (2013).
8. Kisseleva, T. et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45, 429-438 (2006). (Pubitemid 44142115)
9. Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-1669 (2008). (Pubitemid 351615417)
10. De Minicis, S. et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 132, 1937-1946 (2007). (Pubitemid 46677935)
11. Friedman, S. L., Roll, F. J., Boyles, J. & Bissell, D. M. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc. Natl Acad. Sci. USA 82, 8681-8685 (1985). (Pubitemid 16101107)
12. Kisseleva, T. et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl Acad. Sci. USA 109, 9448-9453 (2012).
13. Scholten, D. et al. Genetic labeling does not detect epithelial-to- mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 139, 987-998 (2010).
14. Taura, K. et al. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51, 1027-1036 (2010).
15. Chu, A. S. et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 53, 1685-1695 (2011).
16. Li, Y., Wang, J. & Asahina, K. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc. Natl Acad. Sci. USA 110, 2324-2329 (2013).
17. Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125-172 (2008).
18. Yang, L. et al. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 26, 2104-2113 (2008).
19. Michelotti, G. A. et al. Smoothened is a master regulator of adult liver repair. J. Clin. Invest. 123, 2380-2394 (2013).
20. Blaner, W. S. et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 1791, 467-473 (2009).
21. Nagatsuma, K. et al. Lecithin: retinol acyltransferase protein is distributed in both hepatic stellate cells and endothelial cells of normal rodent and human liver. Liver Int. 29, 47-54 (2009).
22. Yata, Y. et al. DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology 37, 267-276 (2003). (Pubitemid 36152525)
23. Buch, T. et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419-426 (2005). (Pubitemid 40916560)
24. Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193-215 (2011).
25. Asahina, K., Zhou, B., Pu, W. T. & Tsukamoto, H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology 53, 983-995 (2011).
26. Russo, F. P. et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130, 1807-1821 (2006). (Pubitemid 43668827)
27. Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324-1332 (2007). (Pubitemid 350073596)
28. Higashiyama, R. et al. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 137, 1459-1466 e1451 (2009).
29. Sancho-Bru, P. et al. Genomic and functional characterization of stellate cells isolated from human cirrhotic livers. J. Hepatol. 43, 272-282 (2005). (Pubitemid 40956880)
30. Friedman, S. L., Sheppard, D., Duffield, J. S. & Violette, S. Therapy for fibrotic diseases: nearing the starting line. Sci. Transl. Med. 5, 167sr1 (2013).
31. Schuppan, D. & Kim, Y. O. Evolving therapies for liver fibrosis. J. Clin. Invest. 123, 1887-1901 (2013).
32. Schuppan, D. & Pinzani, M. Anti-fibrotic therapy: lost in translation? J. Hepatol. 56(Suppl 1): S66-S74 (2012).
33. Trauner, M., Fickert, P. & Wagner, M. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin. Liver Dis. 27, 77-98 (2007).
34. Espanol-Suner, R. et al. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 143, 1564-1575 e1567 (2012).
35. Malato, Y. et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J. Clin. Invest. 121, 4850-4860 (2011).
36. Zaret, K. S. & Grompe, M. Generation and regeneration of cells of the liver and pancreas. Science 322, 1490-1494 (2008).
37. Lujambio, A. et al. Non-cell-autonomous tumor suppression by p53. Cell 153, 449-460 (2013).
38. Hernandez-Gea, V. et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142, 938-946 (2012).
39. Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85-97 (2010).
40. Hung, C. et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 188, 820-830 (2013).
41. Goritz, C. et al. A pericyte origin of spinal cord scar tissue. Science 333, 238-242 (2011).
42. Lebleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047-1053 (2013).
43. Rock, J. R. et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc. Natl Acad. Sci. USA 108, E1475-E1483 (2011).
44. Zhuo, L. et al. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31, 85-94 (2001). (Pubitemid 33064319)
45. Garcia, A. D., Doan, N. B., Imura, T., Bush, T. G. & Sofroniew, M. V. GFAPexpressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 7, 1233-1241 (2004). (Pubitemid 39426243)
46. Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133-140 (2010).
47. Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global doublefluorescent Cre reporter mouse. Genesis. 45, 593-605 (2007). (Pubitemid 350013057)
48. Popov, Y., Patsenker, E., Fickert, P., Trauner, M. & Schuppan, D. Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J. Hepatol. 43, 1045-1054 (2005). (Pubitemid 41627991)
49. Troeger, J. S. et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143, 1073-1083 e1022 (2012).
50. Mitchell, C. & Willenbring, H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 3, 1167-1170 (2008).
51. Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504-516 (2012).
52. Siegmund, S. V. et al. Fatty acid amide hydrolase determines anandamideinduced cell death in the liver. J. Biol. Chem. 281, 10431-10438 (2006). (Pubitemid 43864582)
53. Pradere, J. P. et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells. Hepatology 58, 1461-1473 (2013).
54. Kluwe, J. et al. Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis. Gut 60, 1260-1268 (2011).
55. Batten, M. L. et al. Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver. J. Biol. Chem. 279, 10422-10432 (2004). (Pubitemid 38372651)